Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Prediction of coronary disease incidence in the general population by circulating RNY(YRNA)-derived small RNA

Vera L. Costa, Jean-Bernard Ruidavet, Vanina Bongard, Bertrand Perret, Emanuela Repetto, Maria G. Stathopoulou, Fabrizio Serra, Mohamed Benahmed, Mauduit Claire, Valerie Grandjean, Jean Ferrières, Laurent O. Martinez, View ORCID ProfileMichele Trabucchi
doi: https://doi.org/10.1101/2020.03.24.20042812
Vera L. Costa
1Inserm U1065, C3M, Team Control of Gene Expression (10), Université Côte d’Azur, Nice, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean-Bernard Ruidavet
2Department of Epidemiology, Health Economics and Public Health, UMR1027 INSERM, Toulouse University, Toulouse University Hospital (CHU), Toulouse, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vanina Bongard
2Department of Epidemiology, Health Economics and Public Health, UMR1027 INSERM, Toulouse University, Toulouse University Hospital (CHU), Toulouse, France
5Fédération de Cardiologie, Toulouse University Hospital (CHU), Toulouse, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bertrand Perret
3Institut National de la Santé et de la Recherche Médicale (INSERM), UMR 1048, Toulouse, France
4University of Toulouse, UMR1048, Paul Sabatier University, Toulouse, France
6Service de Biochimie, Pôle biologie, Hôpital de Purpan, CHU de Toulouse, Toulouse, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emanuela Repetto
1Inserm U1065, C3M, Team Control of Gene Expression (10), Université Côte d’Azur, Nice, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria G. Stathopoulou
1Inserm U1065, C3M, Team Control of Gene Expression (10), Université Côte d’Azur, Nice, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fabrizio Serra
1Inserm U1065, C3M, Team Control of Gene Expression (10), Université Côte d’Azur, Nice, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohamed Benahmed
1Inserm U1065, C3M, Team Control of Gene Expression (10), Université Côte d’Azur, Nice, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mauduit Claire
1Inserm U1065, C3M, Team Control of Gene Expression (10), Université Côte d’Azur, Nice, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Valerie Grandjean
1Inserm U1065, C3M, Team Control of Gene Expression (10), Université Côte d’Azur, Nice, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean Ferrières
2Department of Epidemiology, Health Economics and Public Health, UMR1027 INSERM, Toulouse University, Toulouse University Hospital (CHU), Toulouse, France
5Fédération de Cardiologie, Toulouse University Hospital (CHU), Toulouse, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laurent O. Martinez
2Department of Epidemiology, Health Economics and Public Health, UMR1027 INSERM, Toulouse University, Toulouse University Hospital (CHU), Toulouse, France
3Institut National de la Santé et de la Recherche Médicale (INSERM), UMR 1048, Toulouse, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: michele.trabucchi@univ-cotedazur.fr Laurent.Martinez@inserm.fr
Michele Trabucchi
1Inserm U1065, C3M, Team Control of Gene Expression (10), Université Côte d’Azur, Nice, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michele Trabucchi
  • For correspondence: michele.trabucchi@univ-cotedazur.fr Laurent.Martinez@inserm.fr
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

During the development of atherosclerotic lesion, s-RNYs (small RNAs of about 24/34 nucleotides) are derived by the processing of long Ro-associated non-coding RNAs (RNYs) in macrophages. The levels of serum s-RNYs have been found significantly upregulated in patients with coronary heart disease (CHD) compared to age-matched healthy individuals. The present study aimed to examine the predictive value of serum s-RNYs for CHD events in the general population.

Within the frame of nested-case-control study, the GENES study, we measured the absolute expression of a RNY-derived small RNA, the s-RNY1-5p, in the serum of healthy individuals who encountered a CHD event within 12 years of follow-up (n = 31) (Cases) and compared them to individuals who remained event-free (Controls) (n = 30).

The expression of s-RNY1-5p in serum was significantly upregulated in Cases compared to Controls (p = 0.027). The proportion of CHD event-free was significantly higher among individuals with serum s-RNY1-5p below the median value (631 molecule / mL). In a multivariate model adjusted for age, smoking and treatment for hypertension, diabetes and dyslipidemia, the risk of CHD events increased more than 4-fold in individuals with serum s-RNY1-5p above the median value (HR, 4.36; 95%CI, 1.22-15.60). Significant association with CHD events was also observed when considering s-RNY1-5p as a continuous variable (p = 0.022). Serum s-RNY1-5p is an independent predictor of CHD in healthy individuals and could be considered as a biomarker in primary prevention of cardiovascular diseases.

TRANSLATIONAL PERSPECTIVES Here, we reported that s-RNY1-5p was significantly upregulated in the serum of individuals who underwent CHD and was positively associated with CHD events. Those results argue in favor of s-RNY1-5p being a novel predictive molecular biomarker for cardiovascular events. In the future, measurement of s-RNY1-5p expression levels and other 5’ s-RNYs, such as s-RNY4-5p, could be used in clinical practice in addition to classical risk factors to identify those high-risk individuals who might benefit from prevention medicine.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

V.M-C. was supported by the Satt-SudEst. This work was supported by the ANR through the “Investments for the Future” # ANR-11-LABX-0028-01 (LABEX SIGNALIFE), FRM (grant #DEQ20140329551), Agence de la Biomédecine (AMP, Diagnostic prénatal et diagnostic génétique), Satt-SudEst and the Société Française de Nutrition (Prix de Recherche 2017).

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

all raw data in the manuscript are present in this submission

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted March 26, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Prediction of coronary disease incidence in the general population by circulating RNY(YRNA)-derived small RNA
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Prediction of coronary disease incidence in the general population by circulating RNY(YRNA)-derived small RNA
Vera L. Costa, Jean-Bernard Ruidavet, Vanina Bongard, Bertrand Perret, Emanuela Repetto, Maria G. Stathopoulou, Fabrizio Serra, Mohamed Benahmed, Mauduit Claire, Valerie Grandjean, Jean Ferrières, Laurent O. Martinez, Michele Trabucchi
medRxiv 2020.03.24.20042812; doi: https://doi.org/10.1101/2020.03.24.20042812
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Prediction of coronary disease incidence in the general population by circulating RNY(YRNA)-derived small RNA
Vera L. Costa, Jean-Bernard Ruidavet, Vanina Bongard, Bertrand Perret, Emanuela Repetto, Maria G. Stathopoulou, Fabrizio Serra, Mohamed Benahmed, Mauduit Claire, Valerie Grandjean, Jean Ferrières, Laurent O. Martinez, Michele Trabucchi
medRxiv 2020.03.24.20042812; doi: https://doi.org/10.1101/2020.03.24.20042812

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Cardiovascular Medicine
Subject Areas
All Articles
  • Addiction Medicine (280)
  • Allergy and Immunology (576)
  • Anesthesia (139)
  • Cardiovascular Medicine (1942)
  • Dentistry and Oral Medicine (252)
  • Dermatology (183)
  • Emergency Medicine (331)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (696)
  • Epidemiology (11085)
  • Forensic Medicine (8)
  • Gastroenterology (619)
  • Genetic and Genomic Medicine (3156)
  • Geriatric Medicine (307)
  • Health Economics (560)
  • Health Informatics (2037)
  • Health Policy (861)
  • Health Systems and Quality Improvement (780)
  • Hematology (309)
  • HIV/AIDS (682)
  • Infectious Diseases (except HIV/AIDS) (12702)
  • Intensive Care and Critical Care Medicine (707)
  • Medical Education (317)
  • Medical Ethics (92)
  • Nephrology (334)
  • Neurology (2977)
  • Nursing (162)
  • Nutrition (461)
  • Obstetrics and Gynecology (589)
  • Occupational and Environmental Health (614)
  • Oncology (1548)
  • Ophthalmology (474)
  • Orthopedics (185)
  • Otolaryngology (265)
  • Pain Medicine (201)
  • Palliative Medicine (57)
  • Pathology (402)
  • Pediatrics (909)
  • Pharmacology and Therapeutics (381)
  • Primary Care Research (354)
  • Psychiatry and Clinical Psychology (2773)
  • Public and Global Health (5582)
  • Radiology and Imaging (1090)
  • Rehabilitation Medicine and Physical Therapy (630)
  • Respiratory Medicine (755)
  • Rheumatology (338)
  • Sexual and Reproductive Health (311)
  • Sports Medicine (286)
  • Surgery (342)
  • Toxicology (48)
  • Transplantation (159)
  • Urology (131)